Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia
about
First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemiaHow I treat acquired aplastic anemiaHaploidentical hematopoietic stem cell transplantation in children and adolescents with acquired severe aplastic anemiaAplastic anemia in adolescents and young adultsThe EBMT activity survey: 1990-2010The Latin American experience of allografting patients with severe aplastic anaemia: real-world data on the impact of stem cell source and ATG administration in HLA-identical sibling transplants.Outcomes after related and unrelated umbilical cord blood transplantation for hereditary bone marrow failure syndromes other than Fanconi anemiaImmunosuppressive therapy for transplant-ineligible aplastic anemia patients.Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working PartyEffect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemiaRapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes.Outcome of aplastic anemia in adolescence: a survey of the Severe Aplastic Anemia Working Party of the European Group for Blood and Marrow TransplantationRecent advances in treatment of aplastic anemia.Optimization of therapy for severe aplastic anemia based on clinical, biologic, and treatment response parameters: conclusions of an international working group on severe aplastic anemia convened by the Blood and Marrow Transplant Clinical Trials NeComparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia.Clinical management of aplastic anemia.Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia.Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysisRisk factors for acute GVHD and survival after hematopoietic cell transplantationLong-term follow up after allogeneic stem cell transplantation in patients with severe aplastic anemia after cyclophosphamide plus antithymocyte globulin conditioningRisk Factors, Pattern and Clinical Outcome of Acute Graft Versus Host Disease in Acute Leukemia Patients Undergoing Allogeneic Stem Cell TransplantTacrolimus versus Cyclosporine after Hematopoietic Cell Transplantation for Acquired Aplastic Anemia.HLA-matched sibling transplantation for severe aplastic anemia: impact of HLA DR15 antigen status on engraftment, graft-versus-host disease, and overall survival.Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups.Allogeneic stem cell transplantation in paroxysmal nocturnal hemoglobinuria.Aplastic anemia: pathophysiology and treatment.Evolving hematopoietic stem cell transplantation strategies in severe aplastic anemia.Comparing Outcomes with Bone Marrow or Peripheral Blood Stem Cells as Graft Source for Matched Sibling Transplants in Severe Aplastic Anemia across Different Economic Regions.Anemia of Central Origin.Last marrow standing: bone marrow transplantation for acquired bone marrow failure conditions.Cyclophosphamide conditioning in patients with severe aplastic anaemia given unrelated marrow transplantation: a phase 1-2 dose de-escalation studyFludarabine-based conditioning for marrow transplantation from unrelated donors in severe aplastic anemia: early results of a cyclophosphamide dose deescalation study show life-threatening adverse events at predefined cyclophosphamide dose levels.Success of allogeneic marrow transplantation for children with severe aplastic anaemia.Risk factors affecting outcome of second HLA-matched sibling donor transplantations for graft failure in severe acquired aplastic anemia.Bone marrow T cells are superior to splenic T cells to induce chimeric conversion after non-myeloablative bone marrow transplantationGranulocyte colony-stimulating factor (G-CSF) administration in individuals with sickle cell disease: time for a moratorium?Subsequent donation requests among 2472 unrelated hematopoietic progenitor cell donors are associated with bone marrow harvest.Acquired aplastic anemia in children.The Third Consensus Conference on the treatment of aplastic anemia.
P2860
Q24201108-4ACAE83A-938C-4074-B172-72BF6D93B666Q24617687-2FAFD3D6-F374-46F1-BEAC-3E6B87A0AC89Q26799396-2DB12C96-F1DA-4975-8023-1140746F4D30Q26864775-6EF4E813-0B4B-45AF-A2BD-A171AA6DA34DQ28265604-5A75ECFB-19EF-4867-9A39-1DC357FF1687Q31122890-55A3A591-ABA3-4B92-B995-E927809B8863Q33392788-08C6429B-9F65-4907-8DE7-EA166A83A9C0Q33419679-738EF459-C57B-45B0-8171-B087177110A0Q33430004-F227A7E0-E612-4DB7-AB9A-6069E1FEFCACQ33886206-CB3866A1-832A-4E82-89DD-E9170CF96462Q33945261-57BB4405-29B1-429F-BFD6-8B3F1AB1E160Q34228345-DE75F87F-6E61-451C-9BD9-B859DFDFBD59Q34272519-D190998B-639B-4BEA-9FC5-5DB7D67CEC8FQ34451351-16F66D16-D687-43E4-A575-2E62402FD31CQ34645147-59EE2F7B-C043-4EE2-8FFA-58AC476D8B5AQ35042790-BCA2C2E1-1F9D-4F13-8111-509BD44FFBA3Q35112372-17A37D4E-6AEF-4A34-AB7F-E566FAFCEA43Q35197402-611FEBFA-C81A-4AF4-B407-F62AAA42D264Q35571068-58912050-60D2-44C1-9271-6015BECA66E6Q35651735-7773C463-4957-4B12-8F0A-9173A848F4B0Q35930597-B2E2A630-59B1-41E1-A370-46A95993F50FQ35975019-937AA638-A636-4BCC-8681-0C051C9DBC84Q36055158-84567714-0329-40E0-8729-59607508CF62Q36120565-43F39082-F362-4152-A011-485A43B27B3DQ36133000-6C5ECC2C-9D8E-46B6-A2F9-64D3E7877D04Q36366577-A9DD9F77-493C-4592-B069-B1D148F62F46Q36464602-67F7C1CF-0C81-45B5-95E8-690CB93F0014Q36497220-5318E6FD-4227-45FA-9E36-8FF33498BC3DQ36782730-1C0F900E-28B8-48AE-81AF-A90E50B3D88AQ36784115-493792F1-04AD-4A10-A82F-4B655E417702Q36806501-9BD64F7B-6F85-4F7B-AB42-D07B454B3B38Q36884109-55443196-4FAB-48EA-8843-07623A483964Q36916440-78555A60-EA4F-4ECF-9260-A13147C7DFE3Q36958013-05E9890D-56D2-4ECF-A7AC-1CF0F6A3723DQ37216096-21BF1E29-3044-48B7-A11E-52A7668C4960Q37320975-3D886B30-B3B6-4E69-BB6E-7AD738617CB8Q37354296-FD594F34-1D63-4405-A1BF-4B4DD2828EE9Q37377933-2E4C9485-44E2-4364-BBE3-B6ED7938C058Q37490754-1756B550-3A76-4D3B-AF70-F6F9FDB18579Q37880645-67B4BF41-E578-4919-A8E7-A17F4A553A63
P2860
Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Worse outcome and more chronic ...... evere acquired aplastic anemia
@ast
Worse outcome and more chronic ...... evere acquired aplastic anemia
@en
type
label
Worse outcome and more chronic ...... evere acquired aplastic anemia
@ast
Worse outcome and more chronic ...... evere acquired aplastic anemia
@en
prefLabel
Worse outcome and more chronic ...... evere acquired aplastic anemia
@ast
Worse outcome and more chronic ...... evere acquired aplastic anemia
@en
P2093
P2860
P1433
P1476
Worse outcome and more chronic ...... evere acquired aplastic anemia
@en
P2093
Andrea Bacigalupo
Anna Locasciulli
Antonius V M B Schattenberg
Bruce M Camitta
Christopher N Bredeson
Eduardo Bullorsky
Hubert Schrezenmeier
Jakob R Passweg
John P Klein
Judith C W Marsh
P2860
P304
P356
10.1182/BLOOD-2007-03-081596
P407
P577
2007-05-02T00:00:00Z